Kofi Stevens

Kofi Stevens serves as an Adjunct Lecturer at the Centre for Respiratory Health within the Medical School of The University of Western Australia. His academic work centers on translational cancer immunology, with a focus on leveraging immune responses against solid tumors including neuroblastoma and mesothelioma.

His research spans Cancer Immunotherapy and Tumor Immunology, investigating mechanisms like immune checkpoint blockade and neutrophil modulation to overcome therapy resistance. Key areas include repurposing anti-copper drugs for immunotherapy enhancement and optimizing antibody-based treatments through understanding tumor-infiltrating lymphocyte dynamics.

Recent publications reveal a strong trend toward combinatorial approaches, merging conventional therapies (e.g., anti-metabolite chemotherapy, copper chelation) with immunotherapies to target specific immune pathways in aggressive cancers. This work demonstrates clinically relevant strategies for enhancing treatment efficacy in neuroblastoma and mesothelioma.

Stevens actively secures competitive grant funding, currently leading an active project Repurposing anti-copper drugs to improve anti-mesothelioma immunity (2024-2027, icare NSW) and completing two related studies funded by Cancer Council WA and The University of Western Australia. His collaborative network includes 20+ researchers across immunology, oncology, and translational medicine, with projects generating significant academic engagement (12 Mendeley readers, 3 news outlets, 20+ X users).